Tumor necrosis factor α (TNF-α) and Interleukin 6 (IL-6) can attach to their receptors and trigger cerebral Nuclear factor kappa B (NF-kB) signaling, which can upregulate the production of secondary cytokines, and finally induce depression symptoms. The gene discussed is NFKB1; the disease is depressive disorder.